HomeCompareRMD vs WBA

RMD vs WBA: Dividend Comparison 2026

RMD yields 1.06% · WBA yields 2.09%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RMD wins by $10.8K in total portfolio value· pulled ahead in Year 2
10 years
RMD
RMD
● Live price
1.06%
Share price
$220.03
Annual div
$2.33
5Y div CAGR
35.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.7K
Annual income
$3,288.25
Full RMD calculator →
WBA
WBA
● Live price
2.09%
Share price
$11.98
Annual div
$0.25
5Y div CAGR
-18.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.0K
Annual income
$30.14
Full WBA calculator →

Portfolio growth — RMD vs WBA

📍 RMD pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRMDWBA
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RMD + WBA cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RMD pays
WBA pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RMD
Annual income on $10K today (after 15% tax)
$90.01/yr
After 10yr DRIP, annual income (after tax)
$2,795.01/yr
WBA
Annual income on $10K today (after 15% tax)
$177.38/yr
After 10yr DRIP, annual income (after tax)
$25.62/yr
At 15% tax rate, RMD beats the other by $2,769.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RMD + WBA for your $10,000?

RMD: 50%WBA: 50%
100% WBA50/50100% RMD
Portfolio after 10yr
$26.3K
Annual income
$1,659.19/yr
Blended yield
6.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RMD right now

RMD
Analyst Ratings
16
Buy
14
Hold
5
Sell
Consensus: Buy
Price Target
$295.88
+34.5% upside vs current
Range: $265.00 — $345.00
Altman Z
11.6
Piotroski
7/9
WBA
Analyst Ratings
5
Buy
17
Hold
9
Sell
Consensus: Hold
Price Target
$23.57
+96.7% upside vs current
Range: $9.00 — $57.00
Altman Z
2.3
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RMD buys
0
WBA buys
0
No recent congressional trades found for RMD or WBA in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRMDWBA
Forward yield1.06%2.09%
Annual dividend / share$2.33$0.25
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR35.9%-18.1%
Portfolio after 10y$31.7K$21.0K
Annual income after 10y$3,288.25$30.14
Total dividends collected$10.4K$841.00
Payment frequencyquarterlyquarterly
SectorHealthcareConsumer Staples
Analyst consensusBuyHold
Analyst price target$295.88$23.57

Year-by-year: RMD vs WBA ($10,000, DRIP)

YearRMD PortfolioRMD Income/yrWBA PortfolioWBA Income/yrGap
1$10,844$143.91$10,871$170.91$27.00WBA
2← crossover$11,801$198.21$11,774$142.21+$27.00RMD
3$12,901$273.96$12,716$117.89+$185.00RMD
4$14,185$380.39$13,704$97.46+$481.00RMD
5$15,709$531.20$14,743$80.39+$966.00RMD
6$17,556$747.16$15,842$66.20+$1.7KRMD
7$19,845$1,060.53$17,005$54.45+$2.8KRMD
8$22,757$1,522.63$18,240$44.73+$4.5KRMD
9$26,567$2,217.64$19,554$36.73+$7.0KRMD
10$31,715$3,288.25$20,953$30.14+$10.8KRMD

RMD vs WBA: Complete Analysis 2026

RMDHealthcare

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Full RMD Calculator →

WBAConsumer Staples

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Full WBA Calculator →
📬

Get this RMD vs WBA comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RMD vs SCHDRMD vs JEPIRMD vs ORMD vs KORMD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.